Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2251052 vs meropenem in complicated intra-abdominal infection
2011-000485-35Phase 2Terminated
- Sponsor
- GSK
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of epetraborole in Intra-abdominal infection (IAI) (2 arms), sponsored by GSK. Primary endpoint: Safety evaluation of GSK2251052. Started May 2011; status: terminated.
02
Drugs
epetraborole
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on 2011-000485-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000485-35.